Physician profile
David Moore
NPI 1083307243
$2,864.91
in general payments reported to CMS, 2019-2025
10 companies · $920 in 2025
The $920 reported for 2025 was more than what 90% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $322 · 2024: $1,624 · 2025: $920.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,132 · Travel and Lodging: $733.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,131.86 |
| Travel and Lodging | $733.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,079.10 | 2024-2025 | Misight Contact Lens, Onefit Contact Lens, Clariti Contact Lens |
| Bausch & Lomb Americas INC. | $697.50 | 2023-2025 | Infuse, Biotrue, Biotrue One Day |
| Alcon Vision LLC | $404.22 | 2024-2025 | Dailies Total1 |
| Biotissue Holdings INC. | $205.52 | 2024-2025 | |
| Glaukos Corporation | $162.55 | 2025 | |
| Abbvie INC. | $125.01 | 2023 | |
| Ocular Therapeutix, INC. | $123.20 | 2024 | Dextenza |
| Mallinckrodt Hospital Products INC. | $33.21 | 2025 | Acthar |
| Abb Con-Cise Optical Group LLC | $21.75 | 2023 | Spectacle Lenses, Contact Lens |
| Novartis Pharmaceuticals Corporation | $12.85 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.